3(2H)-isoflavene inhibits Sabin type 2 poliovirus by interfering with virus uncoating, with resistance mediated by specific mutations in the viral capsid proteins.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for poliovirus antivirals; leaves open clinical translation pending human studies.
Salvati et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: